Author

Dania Vázquez‐Blomquist

Centro de Ingeniería Genética y BiotecnologíaORCID 0000-0001-5011-2850Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Lisset HermidaiD· 2 shared Yadira LobainaiD· 2 shared Yasser PereraiD· 2 shared D. Urquiza· 1 shared E. Suzarte· 1 shared Edith SuzarteiD· 1 shared Eva Vonasek· 1 shared Gerardo E GuilléniD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Lisset HermidaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 24, 2026

Integrated Analysis of HeberFERON-Driven Comparative Proteomic regulation in Glioblastoma Cells U-87MG

Dania Vázquez‐Blomquist, Vladimir Besada, Jamilet Miranda…·Iraldo Bello Rivero

This study investigates proteomic changes in glioblastoma cells treated with HeberFERON compared to individual IFNs, identifying multitarget effects and potential pharmacodynamic biomarkers.

DOI 10.64898/2026.04.22.720155

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 28, 2025

Immunological evaluation in African Green Monkeys of two nasal vaccine candidates to induce a broad immunity against coronaviruses

Laura Lazo, E. Suzarte, Diana Vázquez-Blomquist…·Lisset Hermida

This study evaluates two nasal coronavirus vaccines in African Green Monkeys, showing they induce cross-reactive immunity and neutralizing responses against SARS-CoV-2 and related coronaviruses.

DOI 10.1101/2025.05.28.656401

non-human primateexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 9, 2025

A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract.

Yadira Lobaina, Rong Chen, Dania Vázquez‐Blomquist…·Lisset Hermida

This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.

DOI 10.1101/2025.05.09.653001

mouseproteomics

𝕏 PostBluesky